Abstract:A new water-soluble conjugate, consisting of a chlorin-e 6 photosensitizer part, a 4-arylaminoquinazoline moiety with affinity to epidermal growth factor receptors, and a hydrophilic β-D-maltose fragment, was synthesized starting from methylpheophorbide-a in seven steps. The prepared conjugate exhibited low levels of dark cytotoxicity and pronounced photoinduced cytotoxicity at submicromolar concentrations in vitro, with an IC 50 (dark)/IC 50 (light) ratio of ∼368 and a singlet oxygen quantum yield of about 20… Show more
“…However, 194a and 194b showed similar and high photocytotoxicity in several cancer cell lines, indicating the vital role of glycoconjugation in the PDT efficiency of these PSs. In another approach with metalated PS, Fedorov et al reported a water-soluble arylaminoquinazoline–Zn(II) chlorin conjugate ( 195 ) for targeted PDT ( 195b ) . 4-Arylaminoquinazolines have a high affinity for EGFRs, and the hydrophilic β- d -maltose fragment acts as a hydrophilic group.…”
Section: Representative Strategies For Conventional Photosensitizersmentioning
confidence: 99%
“…In another approach with metalated PS, Fedorov et al reported a water-soluble arylaminoquinazoline−Zn(II) chlorin conjugate (195) for targeted PDT (195b). 381 3.2.2. Chlorin e 6 .…”
This review presents a robust strategy to design photosensitizers (PSs) for various species. Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the use of light combined with a light-activated chemical, referred to as a PS. Attractively, PDT is one of the alternatives to conventional cancer treatment due to its noninvasive nature, high cure rates, and low side effects. PSs play an important factor in photoinduced reactive oxygen species (ROS) generation. Although the concept of photosensitizer-based photodynamic therapy has been widely adopted for clinical trials and bioimaging, until now, to our surprise, there has been no relevant review article on rational designs of organic PSs for PDT. Furthermore, most of published review articles in PDT focused on nanomaterials and nanotechnology based on traditional PSs. Therefore, this review aimed at reporting recent strategies to develop innovative organic photosensitizers for enhanced photodynamic therapy, with each example described in detail instead of providing only a general overview, as is typically done in previous reviews of PDT, to provide intuitive, vivid, and specific insights to the readers.
“…However, 194a and 194b showed similar and high photocytotoxicity in several cancer cell lines, indicating the vital role of glycoconjugation in the PDT efficiency of these PSs. In another approach with metalated PS, Fedorov et al reported a water-soluble arylaminoquinazoline–Zn(II) chlorin conjugate ( 195 ) for targeted PDT ( 195b ) . 4-Arylaminoquinazolines have a high affinity for EGFRs, and the hydrophilic β- d -maltose fragment acts as a hydrophilic group.…”
Section: Representative Strategies For Conventional Photosensitizersmentioning
confidence: 99%
“…In another approach with metalated PS, Fedorov et al reported a water-soluble arylaminoquinazoline−Zn(II) chlorin conjugate (195) for targeted PDT (195b). 381 3.2.2. Chlorin e 6 .…”
This review presents a robust strategy to design photosensitizers (PSs) for various species. Photodynamic therapy (PDT) is a photochemical-based treatment approach that involves the use of light combined with a light-activated chemical, referred to as a PS. Attractively, PDT is one of the alternatives to conventional cancer treatment due to its noninvasive nature, high cure rates, and low side effects. PSs play an important factor in photoinduced reactive oxygen species (ROS) generation. Although the concept of photosensitizer-based photodynamic therapy has been widely adopted for clinical trials and bioimaging, until now, to our surprise, there has been no relevant review article on rational designs of organic PSs for PDT. Furthermore, most of published review articles in PDT focused on nanomaterials and nanotechnology based on traditional PSs. Therefore, this review aimed at reporting recent strategies to develop innovative organic photosensitizers for enhanced photodynamic therapy, with each example described in detail instead of providing only a general overview, as is typically done in previous reviews of PDT, to provide intuitive, vivid, and specific insights to the readers.
“…Furthermore, the excessive lipophilicity of these photoactive compounds results in dark toxicity due to aggregation in biological liquids. 13 Some water-soluble derivatives of second-generation PSs are available, although natural compounds with polar side chains are a better alternative. To summarize, an ideal PS should have (i) high chemical purity, (ii) easy synthetic routes, (iii) high photochemical reactivity, (iv) good aqueous solubility and tissue penetration, and (v) excellent biocompatibility.…”
mentioning
confidence: 99%
“…Several research groups have designed and synthesized smart PSs with optimized therapeutic efficacy, such as porphyrin, chlorin, and phthalocyanine derivatives. − The first-generation PS photofrin is widely used in clinical applications despite its low chemical purity (it is a mixture of over 60 molecules), poor tissue penetration (due to absorption of short wavelength at ∼630 nm), and low clearance rates. , The second-generation PSs like benzoporphyrin derivatives, thiopurine derivatives, and phthalocyanines are characterized by higher chemical purity, longer T1 lifetime, higher yields of 1 O 2 and stronger absorption in the red region of the spectrum. , However, the second-generation PSs still have considerable drawbacks such as poor aqueous solubility, poor fluorescence emission and ROS generation, and adjuvant dissolution before administration. Furthermore, the excessive lipophilicity of these photoactive compounds results in dark toxicity due to aggregation in biological liquids . Some water-soluble derivatives of second-generation PSs are available, although natural compounds with polar side chains are a better alternative.…”
The
clinical applications of many photosensitizers (PSs) are limited
because of their poor water solubility, weak tissue penetration, low
chemical purity, and severe toxicity in the absence of light. We designed
a novel chlorin-based PS (designated as HPS) to achieve fluorescence
image-guided photodynamic therapy (PDT) with efficient ROS generation.
In addition to its simple fabrication process, HPS has other advantages
such as excellent water solubility, strong NIR absorption, and high
biocompatibility upon chemical functionalization for enhanced phototherapy.
HPS exhibited high photodynamic performance against lung cancer and
breast cancer cells by generating a large amount of singlet oxygen
(1O2) under 654 nm laser irradiation. HPS accumulated
into multiple organelles such as mitochondria and the endoplasmic
reticulum and triggered cell apoptosis by laser exposure. In the tumor-bearing
mice, in vivo, HPS showed an optimal half-life in
circulation and achieved fluorescence-image-guided PDT within the
irradiation window, resulting in effective tumor growth inhibition
and the prolonged survival of animals. Moreover, the antitumor PDT
effect of HPS was close to the clinical trial phase II stage of HPPH
even at the low dosage of 0.32 mg/kg (under 75 J/cm2 laser),
while the systemic safety of HPS was much higher. In conclusion, HPS
is a novel water-soluble chlorin derivative with excellent PDT potential
for clinical transformation.
“…These results strongly suggest that the Warburg effecta phenomenon where tumors consume higher Glc levels than normal cellscan be utilized in the conception to develop the third-generation PS. Naturally occurring chlorin derivatives are also targeted for glycoconjugation. − Recently, chlorin e6 (Ce6) has been decorated with Glc to develop a new family of PS (Glc–Ce6), which shows an extremely high photocytotoxicity. , Ce6 is a molecule that is derived from naturally occurring chlorophyll a ; therefore, G–Ce6 is expected to show an improved biocompatibility and body clearance, meeting the requirements of both (d) no toxicity in the dark and (e) rapid clearance out of the body after the treatment. However, as a matter of fact, G–Ce6 is insoluble in water due to the strong hydrophobic property of the Ce6 unit.…”
Glycoconjugated chlorins
represent a promising class of compounds
that meet the requirements for the third-generation photosensitizer
(PS) for photodynamic therapy (PDT). We have focused on the use of
glucose (Glc) to improve the performance of the PS based on the Warburg
effect—a phenomenon where tumors consume higher Glc levels
than normal cells. However, as a matter of fact, Glc-conjugation has
a poor efficacy in hydrophilic modification; thus, the resultant PS
is not suitable for intravenous injection. In this study, a Glc-based
oligosaccharide, such as maltotriose (Mal
3
), is conjugated
to chlorin e6 (Ce6). The conjugation is assisted by two additional
molecular tools, such as propargyl amine and a tetraethylene glycol
(TEG) derivative. This route produced the target Mal
3
–Ce6
conjugate linked
via
the TEG spacer (Mal
3
–TEG–Ce6), which shows the required photoabsorption
properties in the physiological media. The PDT test using canine mammary
carcinoma (SNP) cells suggested that the antitumor activity of Mal
3
–TEG–Ce6 is extremely high. Furthermore,
in vitro
tests against mouse mammary carcinoma (EMT6) cells
have been demonstrated, providing insights into the photocytotoxicity,
subcellular localization, and analysis of cell death and reactive
oxygen species (ROS) generation for the PDT system with Mal
3
–TEG–Ce6. Both apoptosis and necrosis of the EMT6 cells
occur by ROS that is generated
via
the photochemical
reaction between Mal
3
–TEG–Ce6 and molecular
oxygen. Consequently, Mal
3
–TEG–Ce6 is shown
to be a PS showing the currently desired properties.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.